RBR-7tqc7k已完成未知
Tamoxifen population pharmacokinetics in breast cancer patients: metabolism study, genetic polymorphism, hormonal status and age
Faculdade de Ciências Farmacêuticas de Ribeirão Preto0 个研究点开始时间: 2018年7月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18Y 至 90Y(—)
- 性别
- Female
入选标准
- •Breast cancer patients on adjuvant tamoxifen treatment for more than 80 days who have not been treated with other co-medications that may interfere with the study have been investigated. For the study, two groups of patients will be delimited according to age and hormonal status, being a premenopausal group (age less than 50 years) and another postmenopause (age higher than 60 years).
排除标准
- •Patients with comorbidities that interfere with the metabolism of tamoxifen and the probe drugs were excluded; patients who have previously chemotherapy and / or target therapy; patients who have contraindications to the use of the probe drugs metoprolol, midazolam and fexofenadine; and psychiatric patients unable to understand ICF.
研究者
相似试验
已完成
不适用
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 PolymorphismsBreast CancerCYP2D6 PolymorphismNCT01075802Western Sydney Local Health District121
招募中
1 期
Pharmacokinetics and pharmacogenomics of Tamoxifen in healthy volunteers: The effects of African specific CYP2D6*17 genotype on the plasma levels of Tamoxifen and its metabolitesCancerPACTR202106791732070AiBST42
已完成
不适用
The Ultrasound Study of TamoxifenBreast NeoplasmsNCT01582074National Cancer Institute (NCI)247
终止
2 期
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer RiskBreast Atypical HyperplasiaBreast Lobular Carcinoma in SituBreast Atypical Lobular HyperplasiaBreast CarcinomaNCT04570956Mayo Clinic65
撤回
不适用
Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRIBreast CancerNCT01297231Memorial Sloan Kettering Cancer Center
